全文获取类型
收费全文 | 5497篇 |
免费 | 362篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 157篇 |
妇产科学 | 133篇 |
基础医学 | 778篇 |
口腔科学 | 129篇 |
临床医学 | 494篇 |
内科学 | 1582篇 |
皮肤病学 | 90篇 |
神经病学 | 303篇 |
特种医学 | 86篇 |
外科学 | 634篇 |
综合类 | 52篇 |
一般理论 | 2篇 |
预防医学 | 408篇 |
眼科学 | 121篇 |
药学 | 301篇 |
1篇 | |
中国医学 | 46篇 |
肿瘤学 | 522篇 |
出版年
2024年 | 6篇 |
2023年 | 66篇 |
2022年 | 89篇 |
2021年 | 190篇 |
2020年 | 94篇 |
2019年 | 172篇 |
2018年 | 163篇 |
2017年 | 121篇 |
2016年 | 115篇 |
2015年 | 147篇 |
2014年 | 198篇 |
2013年 | 285篇 |
2012年 | 472篇 |
2011年 | 437篇 |
2010年 | 270篇 |
2009年 | 205篇 |
2008年 | 342篇 |
2007年 | 395篇 |
2006年 | 350篇 |
2005年 | 363篇 |
2004年 | 343篇 |
2003年 | 321篇 |
2002年 | 259篇 |
2001年 | 24篇 |
2000年 | 16篇 |
1999年 | 34篇 |
1998年 | 36篇 |
1997年 | 26篇 |
1996年 | 39篇 |
1995年 | 17篇 |
1994年 | 29篇 |
1993年 | 17篇 |
1992年 | 13篇 |
1991年 | 15篇 |
1990年 | 11篇 |
1989年 | 7篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1981年 | 15篇 |
1980年 | 13篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1959年 | 4篇 |
排序方式: 共有5884条查询结果,搜索用时 102 毫秒
71.
72.
73.
74.
Guillermo Machuca-Portillo Carmen Cabrerizo-Merino Antonio Cutando-Soriano María J. Giménez-Prats Farncisco J. Silvestre-Donat Inmaculada Tomás-Carmona 《Medicina oral, patología oral y cirugía bucal》2014,19(5):e495-e499
This article summarizes the findings of consensus of the XI congress of the SEOEME. All of these conclusions are referring to the review articles responsible to the general rapporteurs in order to bringing up to date knowledge with regard to the use of implants in patients medically compromised and with special needs and, in the dental management of autism and cerebral palsy, in the dental treatment of patients with genetic and adquired haematological disorders, the dental implications of cardiovascular disease and hospital dentistry.
Key words:Autism, cardiovascular diseases, cerebral palsy, dental implants, disabled patients, haematological disorders, hospital dentistry. 相似文献
75.
John R. Richards Jeff M. Lapoint Guillermo Burillo-Putze 《Clinical toxicology (Philadelphia, Pa.)》2018,56(1):15-24
Introduction: Cannabinoid hyperemesis syndrome is a clinical disorder that has become more prevalent with increasing use of cannabis and synthetic cannabinoids, and which is difficult to treat. Standard antiemetics commonly fail to alleviate the severe nausea and vomiting characteristic of the syndrome. Curiously, cannabinoid hyperemesis syndrome patients often report dramatic relief of symptoms with hot showers and baths, and topical capsaicin.Objectives: In this review, we detail the pharmacokinetics and pharmacodynamics of capsaicin and explore possible mechanisms for its beneficial effect, including activation of transient receptor potential vanilloid 1 and neurohumoral regulation. Putative mechanisms responsible for the benefit of hot water hydrotherapy are also investigated.Methods: An extensive search of PubMed, OpenGrey, and Google Scholar from inception to April 2017 was performed to identify known and theoretical thermoregulatory mechanisms associated with the endocannabinoid system. The searches resulted in 2417 articles. These articles were screened for relevant mechanisms behind capsaicin and heat activation having potential antiemetic effects. References from the selected articles were also hand-searched. A total of 137 articles were considered relevant and included.Capsaicin: Topical capsaicin is primarily used for treatment of neuropathic pain, but it has also been used successfully in some 20 cases of cannabinoid hyperemesis syndrome. The pharmacokinetics and pharmacodynamics of capsaicin as a transient receptor potential vanilloid 1 agonist may explain this effect. Topical capsaicin has a longer half-life than oral administration, thus its potential duration of benefit is longer.Capsaicin and transient receptor potential vanilloid 1: Topical capsaicin binds and activates the transient receptor potential vanilloid 1 receptor, triggering influx of calcium and sodium, as well as release of inflammatory neuropeptides leading to transient burning, stinging, and itching. This elicits a novel type of desensitization analgesia. Transient receptor potential vanilloid 1 receptors also respond to noxious stimuli, such as heat (>43?°C), acids (pH <6), pain, change in osmolarity, and endovanilloids. The action of topical capsaicin may mimic the effect of heat-activation of transient receptor potential vanilloid 1.Endocannabinoid system and transient receptor potential vanilloid 1: Cannabinoid hyperemesis syndrome may result from a derangement in the endocannabinoid system secondary to chronic exogenous stimulation. The relief of cannabinoid hyperemesis syndrome symptoms from heat and use of transient receptor potential vanilloid 1 agonists suggests a complex interrelation between the endocannabinoid system and transient receptor potential vanilloid 1.Temperature regulation: Hot water hydrotherapy is a mainstay of self-treatment for cannabinoid hyperemesis syndrome patients. This may be explained by heat-induced transient receptor potential vanilloid 1 activation.“Sensocrine” antiemetic effects: Transient receptor potential vanilloid 1 activation by heat or capsaicin results in modulation of tachykinins, somatostatin, pituitary adenylate-cyclase activating polypeptide, and calcitonin gene-related peptide as well as histaminergic, cholinergic, and serotonergic transmission. These downstream effects represent further possible explanations for transient receptor potential vanilloid 1-associated antiemesis.Conclusions: These complex interactions between the endocannabinoid systems and transient receptor potential vanilloid 1, in the setting of cannabinoid receptor desensitization, may yield important clues into the pathophysiology and treatment of cannabinoid hyperemesis syndrome. This knowledge can provide clinicians caring for these patients with additional treatment options that may reduce length of stay, avoid unnecessary imaging and laboratory testing, and decrease the use of potentially harmful medications such as opioids. 相似文献
76.
77.
78.
79.
80.
Adekunle Dawodu Barbara Davidson Jessica G. Woo Yong-Mei Peng Guillermo M. Ruiz-Palacios Maria de Lourdes Guerrero Ardythe L. Morrow 《Nutrients》2015,7(2):1081-1093
Although vitamin D (vD) deficiency is common in breastfed infants and their mothers during pregnancy and lactation, a standardized global comparison is lacking. We studied the prevalence and risk factors for vD deficiency using a standardized protocol in a cohort of breastfeeding mother-infant pairs, enrolled in the Global Exploration of Human Milk Study, designed to examine longitudinally the effect of environment, diet and culture. Mothers planned to provide breast milk for at least three months post-partum and were enrolled at four weeks postpartum in Shanghai, China (n = 112), Cincinnati, Ohio (n = 119), and Mexico City, Mexico (n = 113). Maternal serum 25(OH)D was measured by radioimmunoassay (<50 nmol/L was categorized as deficient). Serum 25(OH)D was measured in a subset of infants (35 Shanghai, 47 Cincinnati and 45 Mexico City) seen at 26 weeks of age during fall and winter seasons. Data collected prospectively included vD supplementation, season and sun index (sun exposure × body surface area exposed while outdoors). Differences and factors associated with vD deficiency were evaluated using appropriate statistical analysis. vD deficiency in order of magnitude was identified in 62%, 52% and 17% of Mexican, Shanghai and Cincinnati mothers, respectively (p < 0.001). In regression analysis, vD supplementation (p < 0.01), obesity (p = 0.03), season (p = 0.001) and sites (p < 0.001) predicted maternal vD status. vD deficiency in order of magnitude was found in 62%, 28%, and 6% of Mexican, Cincinnati and Shanghai infants, respectively (p < 0.001). Season (p = 0.022), adding formula feeding (p < 0.001) and a higher sun index (p = 0.085) predicted higher infant vD status. vD deficiency appears to be a global problem in mothers and infants, though the prevalence in diverse populations may depend upon sun exposure behaviors and vD supplementation. Greater attention to maternal and infant vD status starting during pregnancy is warranted worldwide. 相似文献